The sGC stimulator vericiguat reduced hypertension-induced renal damage

被引：0
|
作者：
Kedziora, Sarah M. [1 ,2 ,3 ,4 ,5 ,6 ]
Napieczynska, Hanna [2 ]
Sandner, Peter [7 ]
Heuser, Arnd [2 ]
Dechend, Ralf [1 ,3 ,4 ,5 ,6 ,8 ]
Mueller, Dominik N. [1 ,2 ,3 ,4 ,5 ,6 ]
Haase, Nadine [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Max Delbruck Ctr Mol Med & Charite Univ Med Berli, Expt & Clin Res Ctr, Berlin, Germany
[2] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Berlin, Germany
[3] Charite Univ Med Berlin, Berlin, Germany
[4] Free Univ Berlin, Berlin, Germany
[5] Humboldt Univ, Expt & Clin Res Ctr, Berlin, Germany
[6] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany
[7] Bayer AG, Pharmaceut, Global Drug Discovery, Wuppertal, Germany
[8] HELIOS Clin, Dept Cardiol & Nephrol, Berlin, Germany
来源：
JOURNAL OF TRANSLATIONAL MEDICINE | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
P14
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The sGC stimulator vericiguat reduced hypertension-induced renal damage
    Kedziora, Sarah M.
    Napieczynska, Hanna
    Sandner, Peter
    Heuser, Arnd
    Dechend, Ralf
    Mueller, Dominik N.
    Haase, Nadine
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (SUPPL 1)
  • [2] The sGC stimulator BAY 41-8543 in a rat model of hypertension-induced heart failure
    N Haase
    N Wilck
    L Marko
    A Balogh
    A Heuser
    D Brockschnieder
    A Kretschmer
    J P Stasch
    N Müller
    R Dechend
    BMC Pharmacology and Toxicology, 16 (Suppl 1)
  • [3] Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis
    Ningling Kang
    Thomas Walther
    Xiao-Li Tian
    Jürgen Bohlender
    Akiyoshi Fukamizu
    Detlev Ganten
    Michael Bader
    Journal of Molecular Medicine, 2002, 80 : 359 - 366
  • [4] Reduced hypertension-induced end-organ damage in mice lacking cardiac and renal angiotensinogen synthesis
    Kang, NL
    Walther, T
    Tian, XL
    Bohlender, J
    Fukamizu, A
    Ganten, D
    Bader, M
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2002, 80 (06): : 359 - 366
  • [5] Hypertension-induced renal failure
    Zucchelli, PC
    Pavlica, P
    Zuccalà, A
    Losinno, F
    Barozzi, L
    JOURNAL OF NEPHROLOGY, 2001, 14 (01) : 52 - 67
  • [6] Vericiguat, a novel sGC stimulator: Mechanism of action, clinical, and translational science
    Trujillo, Maria E.
    Ayalasomayajula, Surya
    Blaustein, Robert O.
    Gheyas, Ferdous
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (12): : 2458 - 2466
  • [7] Role of calcitonin gene-related peptide in hypertension-induced renal damage
    Bowers, MC
    Katki, KA
    Rao, A
    Koehler, M
    Patel, P
    Spiekerman, A
    DiPette, DJ
    Supowit, SC
    HYPERTENSION, 2005, 46 (01) : 51 - 57
  • [8] Soluble guanylate cyclase (sGC) stimulator vericiguat as a potential treatment for heart failure
    Follmann, Markus
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [9] Cardioprotective effect of sGC stimulator vericiguat in a rat model for chronic heart failure
    Kedziora, Sarah M.
    Sandner, Peter
    Kraker, Kristin
    Thiele, Arne
    Dechend, Ralf
    Mueller, Dominik N.
    Haase, Nadine
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (SUPPL 1)
  • [10] Development of vericiguat: The first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF)
    Xia, Juan
    Hui, Nan
    Tian, Lei
    Liang, Chengyuan
    Zhang, Jie
    Liu, Jifang
    Wang, Jun
    Ren, Xiaodong
    Xie, Xiaolin
    Wang, Kun
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
12345